Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ORMPOramed Pharmaceuticals Inc.FY2025 · Dec |
|---|---|
| Revenue | $2.00M |
| Revenue, yoy | +49.3% |
| Net income | $64.05M |
| Net income, yoy | +436.0% |
| Net margin | 3,202.5% |
| Free cash flow | $9.15M |
| FCF margin | -457.7% |
| EPS, diluted | $1.50 |
Add another company.